Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of BI 1584862 with Itraconazole in Healthy Male Subjects
NCT06041438Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BI 1584862, sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Concentration-time Curve from 0 to Infinity up to 3 days and Maximum Measured Concentration up to 3 days. Started Sep 2023; status: completed.
02
Drugs
BI 1584862
Beyond the preview
Go deeper on NCT06041438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06041438.